Sorriso Pharmaceuticals

R&D company focused on manufacturing disease-modifying antibodies for multiple therapeutics areas

placeSan Diego, California, United States calendar_todayFounded 2020 groups8 employees language sorrisopharma.com

Innovation

11 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 3,728 times.

YearFilings
20173
20181
20202
20228
20237
20244
20258
20262

Social engagement

Social engagement: 1.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include New Enterprise Associates, Arix Bioscience.

Investor typeCountShare
Venture capital375%
Private equity125%
Coming soon